Phase 2 Study to Evaluate Safety, Pharmacokinetics, Immunogenicity and Pharmacodynamics/Efficacy of EDI200 in Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)

Children's National Medical Center, Washington D.C.

"Azienda Ospedaliera-Polo Universitario Luigi Sacco", Milan

Washington University School of Medicine, St Louis

Hôpital Necker-Enfants Malades, Paris

University Hospital Erlangen, Erlangen

University of California, San Francisco, San Francisco

University Hospital of Wales, Cardiff